In Brazil, from 3 January 2020 to 2:44pm CET, 10 March 2021, there have been 11,051,665 confirmed cases of COVID-19 with 266,398 deaths, reported to WHO.
Since the outbreak of the COVID-19 epidemic, Xiamen Zeesan Biotech Co., Ltd. (referred to as “Zeesan Biotech”) has exported COVID-19 nucleic acid detection related products to more than 60 countries and regions, with an export value of tens of millions of dollars. Currently, the full range of Zeesan Biotech COVID-19 products (sample collection, extraction and detection) has received Brazil’s ANVISA approval.
The details are as follows:
Product 1: Virus RNA Collection Kit (registration number: 81464750074)
The Virus RNA Collection Kit provides an all-in-one system for sample collection, RNA virus lysis/disinfection, viral RNA stabilization and sample transportation for a variety of sample types, including nasopharyngeal swab, oropharyngeal swab, sputum, bronchoalveolar lavage fluid (BALF) and stool swab.
Product 2: Saliva RNA Sample Collection Kit (registration number: 81464750073)
The Saliva RNA Sample Collection Kit provides an all-in-one system for the collection, stabilization and transportation of saliva sample for RNA preservation. This product has obtained several international patents.
Product 3: Lab-Aid 824s Nucleic Acid Extraction System (registration number: 81464750067)
The Lab-Aid 824s Nucleic Acid Extraction System has the advantages of short extraction time, high extraction efficiency, and high level of automation. The system adopts the mode of the 10-tubes cartridge, and is equipped with the functions of heating, UV disinfection, negative pressure of extraction operating room, etc., which allows processing of 1~24 samples in a single run.
Product 4: Lab-Aid Virus RNA Extraction Kit (registration number: 81464750066)
Lab-Aid Virus RNA Extraction Kit utilizes magnetic beads technology for automated isolation and purification of genomic RNA from nasopharyngeal swab, oropharyngeal swab, sputum, bronchoalveolar lavage fluid (BALF) and stool swab.
Product 5: SARS-CoV-2 Test Kit (registration number: 81464750082)
The kit is used for in vitro qualitative detection of novel coronavirus (SARS-CoV-2) ORF1ab and N gene in samples, including nasopharyngeal swab, oropharyngeal swab, bronchoalveolar lavage fluid and stool, for diagnosis of the COVID-19 infection, the suspected cluster cases and of the patients who need differential diagnosis of COVID-19 infection.
Product 6: Real-time Quantitative Thermal Cycler, MA-6000 (registration number: 81464750081)
The instrument is designed to carry out any real-time PCR assay, including fast screening for infectious agents, mutations and SNP analysis, detection of GMO and quantification of cellular RNA levels.
About Zeesan Biotech
Xiamen Zeesan Biotech Co., Ltd. is an ISO 13485:2016-certified manufacturer specialized in providing an integrated solutions for personalized medicine, including molecular diagnostic instruments, reagents, and consumable materials. Zeesan Biotech products are widely used in medical diagnosis for COVID-19, tuberculosis, leukemia, cervical cancer and so on. More than 60 products have got NMPA approval, 50 products are CE marked and 10 products are FDA certificated.